Study to Evaluate the Effects of AZD3427 in Patients with Heart Failure

Trial Identifier: D8330C00002
Sponsor: AstraZeneca
NCTID:: NCT04890548
Start Date: November 2021
Primary Completion Date: August 2022
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Kingdom Cambridge, United Kingdom, CB2 0QQ
United Kingdom London, United Kingdom, W1N 8AA